Last checked at 
LONDON (Alliance News) - PureTech Health PLC said Monday its US affiliate Gelesis will present expanded data from its Gelesis100 study at ObesityWeek in Nashville, Tennessee.
Gelesis100 is the company's lead investigational product for weight loss.
PureTEch Chief of Research & Strategy Eric Elenko said: "We are looking forward to Gelesis' strong presence at ObesityWeek 2018, the preeminent forum that brings together world-renowned experts in obesity to share innovation and breakthroughs in science."
"The expanded data from the pivotal study of lead product candidate, Gelesis100, will provide additional insights around the potential for this exciting new approach to weight loss."
Shares in PureTech Health were up 3.1% Monday at 167.00 pence each.
